Effectiveness and Safety of Immunomodulators with Anti-TNF Therapy in Crohn's Disease

BACKGROUND & AIMS: The benefit of continuing immunomodulators when “stepping up” to anti-tumor necrosis factor (anti-TNF) therapy for Crohn's disease (CD) is uncertain. This study assessed the effectiveness and safety of immunomodulators with anti-TNF therapy in CD. METHODS: We conducted a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Gastroenterol Hepatol
Asıl Yazarlar: Osterman, Mark T., Haynes, Kevin, Delzell, Elizabeth, Zhang, Jie, Bewtra, Meenakshi, Brensinger, Colleen M., Chen, Lang, Xie, Fenglong, Curtis, Jeffrey R., Lewis, James D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4475667/
https://ncbi.nlm.nih.gov/pubmed/25724699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2015.02.017
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller